Voice testing to detect early memory and mood changes
Part of Brain & nervous system, Mental health clinical trials.
This trial studies whether automated analysis of your voice and speech can help detect early signs of Alzheimer’s disease and mood (affective) problems. It may help identify changes sooner, using voice and questionnaire information from people who are cognitively healthy to very mildly affected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 50 or older
- Already have available brain/biomarker test results and memory/thinking test data
- Be cognitively healthy to only very mild dementia (CDR score of 0.5 or less)
- Understand the study language well enough to follow instructions and complete questionnaires
- You must not object to taking part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a French-speaking digital assistant called Talk-to-Jo for people recently diagnosed with mild to moderate memory or thinking problems and their caregivers. The goal is to see if this tool helps both the person with memory issues and the person caring for them.
This trial uses a speech-based artificial intelligence (AI) system to detect early signs of dementia. You will be asked to record your voice during simple tasks, and the AI will analyze your speech patterns to see if they can help identify memory or thinking problems.
This trial uses speech pattern analysis to detect early signs of Alzheimer's. If you're already in a Wisconsin Alzheimer's study, you may help test if your voice can reveal memory changes.
This study uses a video-based system at home to check your speech and memory, helping doctors spot thinking problems early using artificial intelligence. The goal is to see if this simple, at-home test can reliably catch early memory and thinking changes.
This trial studies how hearing relates to early memory and movement problems in Alzheimer's and Parkinson's diseases. It may help find new ways to detect and track these conditions.
This study tests a new assessment tool designed to measure how executive functions (planning, organization, problem-solving) contribute to language and meaning difficulties in people with memory changes. The tool may help doctors better understand cognitive impairment.
Hear when a new Neurocognitive Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.